On December 16, 2020, Dayton Misfeldt provided notice of resignation from his positions with Sunesis Pharmaceuticals, Inc. as interim Chief Executive Officer, effective as of December 31, 2020, in order to pursue another opportunity. In conjunction with Mr. Misfeldt’s resignation, on December 16, 2020, the Board appointed Parvinder S. Hyare, age 50, Senior Vice President, Commercial, as interim Chief Executive Officer, effective January 1, 2021. Mr. Hyare has over 20 years of experience in leadership of organizations across global, national, and regional geographies to drive significant success with commercial and development stage products within biotechnology and pharmaceutical markets. Prior to joining Sunesis, Mr. Hyare was Executive Director, Managed Markets & Reimbursement at AMAG Pharmaceuticals, Inc. and previously served as National Sales Director for that company from 2008 until 2014.